Based on a survey of more than 400 leaders at pharmaceutical and medical technology companies – each with annual revenue exceeding $250 million – nearly all life sciences leaders say GTN has become ...
A 2026 industry survey finds mounting pressure from PBMs, federal pricing reforms, and compliance scrutiny, as manufacturers increase automation and AI investment to manage expanding gross-to-net ...
Thermo Fisher recorded higher third-quarter sales on the back of growth in its life sciences business. The scientific services company reported net income of $1.62 billion, or $4.27 a share, compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results